Lightrock Netherlands B.V. Reduces Lumentum Holdings Stake

Institutional investor trims position in tech company by over 80%

Apr. 16, 2026 at 11:06am

An extreme close-up of the complex, interconnected components that make up a high-tech optical device, conveying the technical sophistication and industrial nature of the industry.An institutional investor's reduced stake in a leading optical technology firm signals potential shifts in market sentiment.San Jose Today

Lightrock Netherlands B.V., an institutional investor, has reduced its stake in Lumentum Holdings Inc. (NASDAQ:LITE) by 83.1% in the fourth quarter, according to a recent SEC filing. The firm now owns 30,921 shares of the technology company's stock, down from 152,334 shares previously.

Why it matters

Lumentum is a leading provider of photonic technologies for high-speed optical communications and industrial applications. Tracking changes in major institutional investors' holdings can provide insights into market sentiment and potential shifts in the company's outlook.

The details

According to the 13F filing, Lightrock Netherlands B.V. sold 152,334 shares of Lumentum, leaving it with a position valued at $11.4 million at the end of the quarter. The firm's holdings in Lumentum now account for approximately 1.2% of its total portfolio.

  • Lightrock Netherlands B.V. reduced its Lumentum stake in the fourth quarter of 2025.

The players

Lightrock Netherlands B.V.

An institutional investor that has reduced its position in Lumentum Holdings Inc.

Lumentum Holdings Inc.

A leading provider of photonic technologies for high-speed optical communications and industrial applications.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Lightrock Netherlands B.V.'s Lumentum stake could signal a shift in market sentiment or a rebalancing of the firm's portfolio, though the reasons behind the move are not explicitly stated. Investors will likely continue to monitor changes in institutional ownership of Lumentum as an indicator of the company's performance and outlook.